Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation-Reference-Cited by-同舟云学术

Spatiotemporal distribution of gp130 cytokines and their receptors after status epilepticus: comparison with neuronal degeneration and microglial activation

Published:2003-01 Issue:2 Volume:122 Page:329-348
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Rosell D.R,Nacher J,Akama K.T,McEwen B.S

Publisher

Elsevier BV

Subject

General Neuroscience

Reference56 articles.

1. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain;Ali;J Cereb Blood Flow Metab,2000

2. Selective increases in cytokine expression in the rat brain in response to striatal injection of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate and interleukin-1;Allan;Brain Res Mol Brain Res,2001

3. Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome;Bensadoun;Eur J Neurosci,2001

4. Distinct populations of cells in the adult dentate gyrus undergo mitosis or apoptosis in response to adrenalectomy;Cameron;J Comp Neurol,1996

5. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6;Campbell;Proc Natl Acad Sci USA,1993

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pyroptosis-Related Genes as Diagnostic Markers in Chronic Obstructive Pulmonary Disease and Its Correlation with Immune Infiltration;International Journal of Chronic Obstructive Pulmonary Disease;2024-06

2. Interleukins in Epilepsy: Friend or Foe;Neuroscience Bulletin;2024-01-24

3. Minocycline prevents hypoxia-induced seizures;Frontiers in Neural Circuits;2023-03-22

4. Downregulation of the Astroglial Connexin Expression and Neurodegeneration after Pilocarpine-Induced Status Epilepticus;International Journal of Molecular Sciences;2022-12-20

5. Oncostatin M: Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis;Current Drug Targets;2022-10